CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $62,000 | -56.6% | 12,344 | +9.4% | 0.00% | -100.0% |
Q4 2020 | $143,000 | +15.3% | 11,282 | +9.5% | 0.00% | 0.0% |
Q1 2019 | $124,000 | -3.1% | 10,307 | +1.3% | 0.00% | 0.0% |
Q4 2018 | $128,000 | -28.9% | 10,171 | -16.3% | 0.00% | 0.0% |
Q3 2018 | $180,000 | -15.5% | 12,153 | -3.8% | 0.00% | 0.0% |
Q2 2018 | $213,000 | -27.6% | 12,635 | -1.4% | 0.00% | -50.0% |
Q1 2018 | $294,000 | -23.8% | 12,820 | -14.1% | 0.00% | -33.3% |
Q4 2017 | $386,000 | +144.3% | 14,931 | -4.6% | 0.00% | +50.0% |
Q3 2016 | $158,000 | -24.0% | 15,648 | -15.7% | 0.00% | -33.3% |
Q2 2016 | $208,000 | -16.5% | 18,558 | +1.8% | 0.00% | 0.0% |
Q1 2016 | $249,000 | -34.3% | 18,232 | -8.8% | 0.00% | -40.0% |
Q4 2015 | $379,000 | +11.1% | 19,998 | +9.9% | 0.01% | 0.0% |
Q3 2015 | $341,000 | +18.8% | 18,189 | -5.7% | 0.01% | +25.0% |
Q2 2015 | $287,000 | +29.3% | 19,296 | +31.7% | 0.00% | +33.3% |
Q1 2015 | $222,000 | +38.8% | 14,653 | +21.7% | 0.00% | +50.0% |
Q4 2014 | $160,000 | – | 12,044 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |